The company under Elon Musk said that the progress of brain-computer interface is going smoothly

The second human implantation of the brain-computer interface of Neuralink, a company under Elon Musk, is progressing smoothly.

On August 23, 2024, Neuralink, the brain-computer interface company under Elon Musk, announced that its second human implantation of brain-computer interface device was successful and "progressing smoothly".

In July, in this operation performed at the Barrow Neurological Institute in the United States, Alex, the recipient, was discharged on the second day after the operation, and the recovery process was very smooth. With the help of the brain-computer interface device, Alex has enhanced his ability in playing video games and has also started to learn to use computer-aided design software to design three-dimensional object models. After connecting the brain and the computer, Alex can control the cursor with his mind in less than five minutes, and there is no "retraction of the implant wire" problem that occurred in Nolan Abo, the first recipient.

On January 28 this year, Neuralink carried out the first human implantation of brain-computer interface device. After the operation, Abo had a certain degree of "retraction of the implant wire". Although the situation has stabilized, this problem once reduced the performance of the brain-computer interface. To avoid a similar situation in the second operation, the company has taken a series of measures such as reducing the gap between the implant and the brain surface.

Neuralink was founded in 2016 and focuses on researching and developing implantable brain-computer interface devices. The company said that after the device is implanted in the brain, it can read brain activity signals and is expected to be used to treat memory decline, cervical spinal cord injury and other neurological diseases, and help paralyzed people restore their ability to communicate with the outside world and even walk again. In May last year, the company was approved by the US Food and Drug Administration to start human clinical trials of brain-computer interface implant devices. The development of this technology has brought new hope to many patients with neurological diseases and also attracted extensive attention from the scientific community and all sectors of society.